Results 251 to 260 of about 133,046 (390)
Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide
Alimentary Pharmacology &Therapeutics, EarlyView.Most therapies used in inflammatory bowel disease appear safe and effective when used in chronic kidney disease including on renal replacement therapy, particularly biologic therapies. Some caution should be considered when using conventional therapies and JAK inhibitors.
Lynna Chen +6 more
wiley +1 more source
Fast atrial fibrillation induced by azathioprine [PDF]
, 1985 Pascal C. Chijioke
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Cyclophosphamide for clinical renal and hepatic transplantation. [PDF]
, 1973 Cascardo, S +10 more
core
Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease
Alimentary Pharmacology and Therapeutics, 2014 T. Dassopoulos +7 more
semanticscholar +1 more source
British Journal of Pharmacology, EarlyView.Abstract Background and purpose Thiopurines are used in paediatric inflammatory bowel disease (IBD), but some patients do not respond. Because the gut microbiota influences drug efficacy and IBD‐patient microbiota presents increased bacterial abundance, we investigated the impact of candidate Enterobacteriaceae on drug cytotoxicity, metabolism and ...
Martina Franzin +13 more
wiley +1 more source
Severe Treatment-Resistant Methemoglobinemia of Unknown Etiology With Recurrence. [PDF]
Case Rep Crit CareAinsworth J, Pillai S.
europepmc +1 more source